XML 11 R2.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Revenues:        
Total revenues $ 82,130 $ 70,079 $ 237,011 $ 208,728
Expenses:        
Cost of goods sold - commercial 4,498 3,197 12,873 12,621
Research and development 14,063 12,926 38,760 34,755
Selling, general and administrative 29,088 23,916 85,724 70,357
(Gain) loss on foreign currency transaction (120) 2,454 7,752 526
Total expenses 63,234 57,319 190,523 162,636
Income from operations 18,896 12,760 46,488 46,092
Other income (expense):        
Interest income, net 2,628 3,179 6,416 9,790
Interest expense (1,364) (1,801) (6,294) (10,419)
Interest expense on liability for sale of future royalties (3,514) (4,089) (10,564) (12,720)
Interest expense on financing liability (2,456) (2,470) (7,299) (7,361)
Impairment of available-for-sale investment (6,409)   (6,409) (1,550)
Other Income   32   32
Gain on bargain purchase   5,259   5,259
Loss on settlement of debt       (7,050)
Total other (expense) income (11,115) 110 (24,150) (24,019)
Income before income tax (benefit) expense 7,781 12,870 22,338 22,073
Income tax (benefit) provision (204) 1,320 527 1,907
Net income $ 7,985 $ 11,550 $ 21,811 $ 20,166
Net income per share $ 0.03 $ 0.04 $ 0.07 $ 0.07
Weighted average shares used to compute net income per share - basic 306,806 274,998 305,093 272,811
Net income per share - diluted $ 0.03 $ 0.04 $ 0.07 $ 0.07
Weighted average shares used to compute net income per share - diluted 311,638 284,693 313,339 281,407
Commercial product sales        
Revenues:        
Total revenues $ 22,305 $ 19,728 $ 63,732 $ 59,272
Collaborations and services        
Revenues:        
Total revenues 26,506 23,268 78,727 74,130
Expenses:        
Cost of revenue 15,705 14,826 45,414 44,377
Royalties        
Revenues:        
Total revenues $ 33,319 $ 27,083 $ 94,552 $ 75,326